EP3990438A1 - Hydroxy-functionalized triazine compounds. curable fluoropolymer compositions comprising such compounds and cured articles therefrom - Google Patents

Hydroxy-functionalized triazine compounds. curable fluoropolymer compositions comprising such compounds and cured articles therefrom

Info

Publication number
EP3990438A1
EP3990438A1 EP20737553.6A EP20737553A EP3990438A1 EP 3990438 A1 EP3990438 A1 EP 3990438A1 EP 20737553 A EP20737553 A EP 20737553A EP 3990438 A1 EP3990438 A1 EP 3990438A1
Authority
EP
European Patent Office
Prior art keywords
ocfh
curable composition
formula
hoch
ocf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20737553.6A
Other languages
German (de)
French (fr)
Other versions
EP3990438B1 (en
Inventor
Miguel A. Guerra
Tatsuo Fukushi
Michael H. MITCHELL
Zai-Ming Qiu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of EP3990438A1 publication Critical patent/EP3990438A1/en
Application granted granted Critical
Publication of EP3990438B1 publication Critical patent/EP3990438B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/34—Heterocyclic compounds having nitrogen in the ring
    • C08K5/3467—Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
    • C08K5/3477—Six-membered rings
    • C08K5/3492—Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/24—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to three ring carbon atoms

Definitions

  • a hydroxy-functionalized triazine compound is described along with a method of making such a compound. Also described are curable fluoropolymer compositions comprising such compounds and cured articles therefrom.
  • each Rf is independently selected from a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1 to 3.
  • a curable composition comprising (a) an amorphous fluorinated polymer capable of being dehydrofluorinated, and (b) the compound according to Formula I.
  • the curable composition from above is cured to form an article such as an o- ring, a seal, a gasket, a hose, or a sheet.
  • a and/or B includes, (A and B) and (A or B);
  • backbone refers to the main continuous chain of the polymer
  • crosslinking refers to connecting two pre-formed polymer chains using chemical bonds or chemical groups
  • cure site refers to functional groups, which may participate in crosslinking
  • interpolymerized refers to monomers that are polymerized together to form a polymer backbone
  • “monomer” is a molecule which can undergo polymerization which then form part of the essential structure of a polymer
  • perfluorinated means a group or a compound derived from a hydrocarbon wherein all hydrogen atoms have been replaced by fluorine atoms.
  • a perfluorinated compound may however still contain other atoms than fluorine and carbon atoms, like oxygen atoms, chlorine atoms, bromine atoms and iodine atoms; and
  • polymer refers to a macrostructure having a number average molecular weight (Mn) of at least 30,000 dalton, at least 50,000 dalton, at least 100,000 dalton, at least 300,000 dalton, at least 500,000 dalton, at least, 750,000 dalton, at least 1,000,000 dalton, or even at least 1,500,000 dalton and not such a high molecular weight as to cause premature gelling of the polymer.
  • Mn number average molecular weight
  • “at least one” includes all numbers of one and greater (e.g., at least 2, at least 4, at least 6, at least 8, at least 10, at least 25, at least 50, at least 100, etc.).
  • “comprises at least one of" A, B, and C refers to element A by itself, element B by itself, element C by itself, A and B, A and C, B and C, and a combination of all three.
  • the present disclosure is directed toward a compound according to formula I. Along with a method of making such compound as well as their use curable fluoropolymer compositions.
  • each Rf is independently selected from a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1, 2, or 3.
  • Rf is a divalent perfluorinated group comprising 2 to 12 carbon atoms. In one embodiment Rf comprises at least 2, 3, 4, 5, 6, or even 8 carbon atoms. In one embodiment Rf comprises at most 6, 8, 10 or even 12 carbon atoms. Rf may be linear, branched, and/or cyclic in nature. In one embodiment, Rf is linear alkylene, such as
  • Rf is a branched alkylene such as -[(CF 2 CF(CF 3 )] n -, where n is an integer of at least 2, 3, 4; and at most 5, 6, 7, or even 8.
  • Rf may optionally contain at least one catenated oxygen (i.e., ether) and/or nitrogen (i.e., amine) atom.
  • Rf may comprise -(CF 2 ) p -O-(CF 2 ) q - , -(OCF 2 CF 2 ) q - , -(OCF 2 CF(CF 3 )) p - and/or -(CF 2 CF(CF 3 )) p -O-(CF 2 ) q - wherein p is an integer of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 and q is an integer from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11, such that the sum of p+q is 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12.
  • the Rf groups may or may not be same, however, it is preferable that the three Rf groups in Formula (I) are identical.
  • the compound according to Formula I are small molecules, having a molecular weight of at least 600 g/mole and less than 5000, 4000, 3000, 2500, 2200, 2000, 1800, 1500, 1200, or even 1000 grams/mole.
  • Exemplary compounds of Formula (I) include:
  • the compounds according to Formula (I) may be made by reacting a hydroxy alkylene perfluorovinyl ether with excess ammonia to produce a hydroxy alkylene hydrofluoroether amidine. This reaction may be done directly or can be done in multiple steps by first isolating the hydroxy alkylene hydrofluoroether nitrile intermediate and adding additional ammonia to make the corresponding hydroxy alkylene hydrofluoroether amidine.
  • hydrofluoroether amidines can then be heated to isolate the trifunctional hydrofluoroether triazines.
  • Rf and m are the same as defined above.
  • the amidine molecule of Formula (IV) can be derived by adding another mole of ammonia to the nitrile molecule of Formula (III) or adding excess ammonia to Formula (II) to isolate the amidine molecule directly.
  • the amidine molecule of Formula (IV) can then be heated to arrive at the compound according to Formula (I).
  • the formed nitrile molecule of Formula (III) can also be directly cyclized to form the compound of Formula (I) under heat, which can be accelerated, for example, in the presence of a catalytic amount of ammonia.
  • the vinyl ether monomer is of the structure according to Formula (II):
  • Rf is a perfluorinated divalent group as described above; and m is 1, 2, or 3.
  • Exemplary vinyl ether monomers according to Formula (II) include:
  • the vinyl ether monomer according to Formula (II) is reacted with a controlled amount (for example 3 moles of ammonia per mole of vinyl ether monomer) of ammonia (NH 3 ) to form the corresponding nitrile molecule, HO(CH 2 ) m - Rf-O-CHF-CN (III), wherein Rf and m are described above.
  • Exemplary nitrile molecules according to Formula (III) include:
  • Exemplary amidine molecules according to Formula (IV) include:
  • amidine molecule is then heated to temperature of at least 100°C, 120°C, or even 140°C and, in some embodiments, at most 200°C, for cyclization of the amidine molecules to form the compound according to Formula (I) along with ammonia.
  • a solvent is used to aid the reaction even though the reactions may be done in the absence of a solvent.
  • the selected solvent is a polar aprotic solvent, which has some solubility to the reactants to enable a fast reaction.
  • the used solvent is anhydrous in order to eliminate the hydrolysis side reaction of nitrile.
  • Solvents that can be used, but not limited to are 1,4-dioxane, methyl -t-butyl ether, monoglyme, diglyme, triglyme, tetrahydrofuran, N-methyl pyrrolidone, N,N-dimethyl formamide, sulfolane, and acetonitrile. Methyl -t-butyl ether is the preferred solvent.
  • Addition of ammonia to the vinyl ether monomer to form the nitrile and/or amidine molecules can be done from -35°C to 50°C. Preferably from -10°C to 25°C and more preferably from -5°C to 10°C. Pressure in the reaction can range from 0 psi (pounds per square inch) to 100 psi, preferably from 10 psi to 75 psi and more preferably form 15 psi to 50 psi.
  • the ratio of ammonia to the vinyl ether monomer to form the amidine molecule according to Formula (IV) can be from at least 3, 4, 5, 6, or even 7 moles of ammonia to 1 mole vinyl ether monomer. In one embodiment, the ratio of ammonia to the vinyl ether monomer of Formula (II) to form the amidine molecule according to Formula (IV) is no more than 8, or even 10 moles of ammonia to 1 mole of the vinyl ether monomer.
  • the desired reaction product can be isolated using techniques known in the art. For example, isolation of the nitrile molecule can be done by first filtration of the ammonium fluoride salt, removing the solvent by distillation or rotary evaporation and final distillation to isolate the nitrile molecule. A similar procedure is followed when isolating the amidine molecule, except the amidine molecule is not distilled.
  • the resulting triazine-containing compound according to Formula (I) is in a purified form, which means the compound according to Formula (I) is at least 75, 80, 85, 90, 95, 98, or even 99 wt% pure.
  • the compounds according to Formula (I) may be used as a crosslinking agent in the curing of amorphous fluorinated polymers.
  • the compound according to Formula (I) is combined with an amorphous partially fluorinated polymer capable of being dehydrofluorinated to form a fluoroelastomer.
  • the amorphous partially fluorinated polymer capable of being dehydrofluorinated is a polymer comprising carbon-carbon double bonds and/or is capable of forming carbon-carbon double bonds along the polymer chain under desired curing conditions.
  • the amorphous partially fluorinated polymer is a polymer comprising at least one carbon- hydrogen bond adjacent to a carbon-fluorine bond on the backbone of the polymer.
  • the amorphous partially fluorinated polymer is highly fluorinated, wherein at least 60, 70, 80, or even 90% of the polymer backbone comprises C-F bonds.
  • the amorphous partially fluorinated polymer of the present disclosure comprises carbon- carbon double bonds and/or is capable of forming carbon-carbon double bonds along the polymer chain.
  • the amorphous partially fluorinated fluoropolymer comprises carbon- carbon double bonds along the backbone of the partially fluorinated amorphous fluoropolymer or is capable of forming carbon-carbon double bonds along the backbone of the partially fluorinated amorphous fluoropolymer.
  • the amorphous partially fluorinated fluoropolymer comprises carbon-carbon double bonds or is capable of forming carbon-carbon double bonds in a pendent group off of the backbone of the partially fluorinated amorphous fluoropolymer.
  • the fluoropolymer capable of forming carbon-carbon double bonds means that the fluoropolymer contains units capable of forming double bonds. Such units include, for example, two adjacent carbons along the polymer backbone or pendent side chain, wherein a hydrogen is attached to the first carbon and a leaving group is attached to the second carbon. During an elimination reaction (e.g., thermal reaction, and/or use of acids or bases), the leaving group and the hydrogen leave forming a double bond between the two carbon atoms.
  • an elimination reaction e.g., thermal reaction, and/or use of acids or bases
  • An exemplary leaving group includes: a halide, an alkoxide, a hydroxide, a tosylate, a mesylate, an amine, an ammonium, a sulfide, a sulfonium, a sulfoxide, a sulfone, and combinations thereof. Also contemplated would be a fluoropolymer comprising adjacent carbons either having both bromine or both iodine atoms attached resulting in the leaving of Br 2 or I 2 .
  • the amorphous partially fluorinated polymer comprises a plurality of these groups (carbon-carbon double bonds or groups capable of forming double bonds) to result in a sufficient cure. Generally, this means at least 0.1, 0.5, 1, 2, or even 5 mol % at most 7, 10, 15, or even 20 mol % (i.e., moles of these carbon-carbon double bonds or precursors thereof per mole of polymer).
  • the amorphous partially fluorinated polymer is derived from at least one hydrogen containing monomer such as vinylidene fluoride.
  • the amorphous partially fluorinated polymer comprises adjacent copolymerized units of vinylidene fluoride (VDF) and hexafiuoropropylene (H FP ): copolymerized units of VDF (or tetrafluoroethylene) and a fluorinated comonomer capable of delivering an acidic hydrogen atom to the polymer backbone, such as trifluoroethylene; vinyl fluoride; 3,3,3- trifluoropropene-1; pentafluoropropene (e.g., 2-hydropentafluoropropyiene and 1 - hydropentafluoropropylene); 2,3,3,3-tetrafluoropropene; and combinations thereof.
  • VDF vinylidene fluoride
  • H FP hexafiuoropropylene
  • small amounts e.g., less than 10, 5, 2, or even 1 wt%) of additional monomers may be used to derive the amorphous partially fluorinated polymer so long as the fluorinated polymer is able to be cured with the compound of Formula (I) as disclosed herein, and optionally with a polyhydroxy curative.
  • the amorphous partially fluorinated polymer is additionally derived from a hydrogen containing monomer including: pentafluoropropylene (e.g., 2- hydropentafluropropylene), propylene, ethylene, isobutylene, and combinations thereof.
  • pentafluoropropylene e.g., 2- hydropentafluropropylene
  • propylene ethylene
  • isobutylene and combinations thereof.
  • the amorphous partially fluorinated polymer is additionally derived from a perfluorinated monomer.
  • exemplary perfluorinated monomers include: hexafluoropropene; tetrafluoroethylene; chlorotrifluoroethylene; perfluoro ether monomers, and combinations thereof.
  • Exemplary perfluoro ether monomers are of the Formula (III)
  • CF 2 CF(CF 2 ) b O(R f" O) n (R f' O) m R f (III) where R f" and R f' are independently linear or branched perfluoroalkylene radical groups comprising 2, 3, 4, 5, or 6 carbon atoms, m and n are independently an integer selected from 0, 1,
  • R f is a perfluoroalkyl group comprising 1, 2, 3, 4, 5, or 6 carbon atoms.
  • Exemplary types of amorphous partially fluorinated polymers include those comprising interpolymerized units derived from (i) vinylidene fluoride, tetrafluoroethylene, and propylene; (ii) vinylidene fluoride with hexafluoropropylene; (iii) hexafluoropropylene, tetrafluoroethylene, and vinylidene fluoride; (iv) hexafluoropropylene and vinylidene fluoride, (v) tetrafluoroethylene, propylene, and 3,3,3-trifluoropropene; (vi) tetrafluoroethylene, and propylene; and (vii) blends thereof.
  • the amorphous partially fluorinated polymer is cured with the compound according to Formula (I) and is substantially free (having less than 0.05, less than 0.01, less than 0.05 wt% or even none relative to the amorphous partially fluorinated polymer) of a traditional curative (such as peroxide, and/or polyhydroxy curing agent).
  • a traditional curative such as peroxide, and/or polyhydroxy curing agent.
  • at least 0.05, 0.1, 1, 2, 3, or even 4 parts; and at most 5, 10, 15, 20, or even 25 parts by weight of the compound according to Formula (I) is used per 100 parts by weight of amorphous partially fluorinated polymer.
  • the extent of the cure and performance can be evaluated by cure rheology, hardness, tensile properties (such as tensile at break, elongation at break, tensile at 50% elongation, and/or tensile at 100% elongation), and/or compression set.
  • the composition comprises a
  • dehydrofluorinating agent examples include organoonium compounds, such as quaternary ammonium hydroxides or salts, quaternary phosphonium hydroxides or salts, and ternary sulfonium hydroxides or salts.
  • a phosphonium and ammonium salts or compounds comprise a central atom of phosphorous or nitrogen, respectively, covalently bonded to four organic moieties by means of a carbon-phosphorous (or carbon-nitrogen) covalent bonds and is ionieally associated with an anion.
  • the organic moieties can be the same or different.
  • a sulfonium compound is a sulfur-containing organic compound in which at least one sulfur atom is covalently bonded to three organic moieties having from 1 to 20 carbon atoms by means of carbon-sulfur covalent bonds and is ionieally associated with an anion
  • the organic moieties can be the same or different.
  • the sulfonium compounds may have more than one relatively positive sulfur atom, e.g.
  • Organo-onium compounds are known in the art, such as in U.S. Pat. No. 4,233,421 (Worm), U.S. Pat. No. 4,912,171 (Grootaert et al.), U.S. Pat. No. 5,086,123 (Guenthner et al.), and U.S. Pat. No. 5,262,490 (Kolb et al.), and U.S. Pat. No. 5,929,169, all of whose descriptions are herein incorporated by reference.
  • Another class of useful organo-onium compounds include those having one or more pendent fluorinated alkyl groups. Generally, the most useful fluorinated onium compounds are disclosed in U.S. Pat. No. 5,591,804 (Coggio, et al.).
  • Exemplary organoonium compounds include: C 3 -C 6 symmetrical tetraalkylammomum salts, unsymmetrical tetraalkylammonium salts wherein the sum of alkyl carbons is between 8 and 24 and benzyltrialkylammonium salts wherein the sum of alkyl carbons is between 7 and 19 (for example tetrabutylammonium bromide, tetrabutylammonium chloride, benzyltributylammonium chloride, benzyltriethylammomum chloride, tetrabutylammonium hydrogen sulfate and tetrabutylammonium hydroxide, phenyltrimethylammonium chloride, tetrapentylammonium chloride, tetrapropylammonium bromide, tetrahexylammonim chloride, and tetraheptylammonium bromidet
  • tetrabutylphosphoniuin salts tetraphenylphosphonium chloride, benzyltriphenylphosphonium chloride, tributylallylphospbonium chloride, tributylbenzyl phosphonium chloride, tributyl-2- methoxypropylphosphonium chloride, benzyldiphenyl(dimethylamino)phosphonium chloride, 8- benzyl-1,8-diazobicyclo[5.4.0]7-undecenium chloride, benzyltris(dimethylamino)phosphonium chloride, and bis(benzyldiphenylphosphine)iminium chloride.
  • organoonium compounds include 1 ,8-diazabicyclo[5.4.0]undec-7-ene and 1,5-diazabicyclo[4.3.0]non-5-ene.
  • Phenolate is a preferred anion for the quaternary ammonium and phosphonium salts.
  • the organoonium compound is used from at least 1, 1.5, 2, or even 2.5 millimoles and at most 3.5, 4, 4.5 or even 5 millimoles per 100 parts (by weight in grams) of the amorphous partially fluorinated polymer.
  • the curable composition comprises an organic or inorganic base.
  • bases include Ca(OH) 2 , 1,8-diazobicyclo[5,4,0]undec-7-ene (DBU), triethylamine, and tributyl amine.
  • DBU salt 1,8-diazabicyclo(5.4.0)undec-7-ene salt
  • DBN salt 1,5-diazabicyclo(4.3.0)-non- 5-ene salt
  • DBN salt 1,5-diazabicyclo(4.3.0)-non-5-ene
  • the amorphous partially fluorinated polymer in curable composition should be substantially free of iodine, bromine, and/or nitrile cure sites, meaning that the fluorinated polymer comprises less than 0.1, 0.05, 0.01, or even 0.005 wt% or even no I, Br, and CoN versus the weight of the amorphous partially fluorinated polymer.
  • the curable compositions can also contain a wide variety of additives of the type normally used in the preparation of elastomeric compositions, such as acid acceptors, process aides, pigments, fillers, pore-forming agents, and those known in the art.
  • Such fillers include: an organic or inorganic filler such as clay, silica (SiO 2 ), alumina, iron red, talc, diatomaceous earth, barium sulfate, wollastonite (CaSiO 3 ). calcium carbonate (CaCO 3 ), calcium fluoride, titanium oxide, iron oxide and carbon black fillers, a polytetrafluoroethylene powder, PFA (TFE/perfluorovinyl ether copolymer) powder, an electrically conductive filler, a heat-dissipating filler, and the like may be added as an optional component to the composition.
  • an organic or inorganic filler such as clay, silica (SiO 2 ), alumina, iron red, talc, diatomaceous earth, barium sulfate, wollastonite (CaSiO 3 ).
  • CaCO 3 calcium carbonate
  • calcium fluoride titanium oxide
  • PFA TFE
  • the filler components may result in a cured product that is capable of retaining a preferred elasticity and physical tensile, as indicated by an elongation and tensile strength value, while retaining desired properties such as retraction at lower temperature (TR-10).
  • the curable composition and/or cured product comprises less than 40, 30, 20, 15, or even 10% by weight of the filler.
  • acid acceptors may be employed to facilitate the cure and thermal stability of the compound.
  • Suitable acid acceptors may include magnesium oxide, lead oxide, calcium oxide, calcium hydroxide, dibasic lead phosphite, zinc oxide, barium carbonate, strontium hydroxide, calcium carbonate, hydrotalcite, alkali stearates, magnesium oxalate, or combinations thereof.
  • the acid acceptors are preferably used in amounts ranging from at least 1, 2, 4, or even 5%; and at most 10, 15, or even 20 % weight per weight of the fluorinated polymer.
  • the curable compositions (and the resulting cured articles) are substantially free of inorganic acid acceptors, meaning that the curable composition (or resulting cured article) contains less than 0.5, 0.1, 0.05, 0.01 % be weight per weight of the fluorinated polymer, or even no inorganic acid acceptor.
  • the curable composition comprises a fluoroaliphatic sulfonamide.
  • a fluoroaliphatic sulfonamide include C 4 F 4 SO 2 NHCH 3 , and CF 3 -(arylC 6 F 4 )-CF 2 SO 2 NHC 2 H 5 as disclosed in U.S. Pat. No.
  • Such fluoroaliphatic sulfonamides may be used in at least 0.25, 0.5, 1, 2, or even 4 % and no more than 5, 8, or even 10% by weight based on the weight of the fluorinated polymer.
  • the curable compositions may be prepared by mixing the compound of Formula (I), the amorphous fluorinated polymer, and any additional components in conventional rubber processing equipment to provide a solid mixture, i.e. a solid polymer containing the additional ingredients, also referred to in the art as a“compound”.
  • a solid mixture i.e. a solid polymer containing the additional ingredients, also referred to in the art as a“compound”.
  • This process of mixing the ingredients to produce such a solid polymer composition containing other ingredients is typically called“compounding”.
  • Such equipment includes rubber mills, internal mixers, such as Banbury mixers, and mixing extruders.
  • the temperature of the mixture during mixing typically will not rise above about 120°C.
  • The“compound” can then be extruded or pressed in a mold, e.g., a cavity or a transfer mold and subsequently be oven-cured.
  • curing can be done in an autoclave.
  • Pressing of the compounded mixture is typically conducted at a temperature of about 120-220°C, preferably about 140-200°C, for a period of about 1 minute to about 15 hours, usually for about 1-15 minutes.
  • a pressure of about 700-20,000 kPa, preferably about 3400- 6800 kPa, is typically used in molding the composition.
  • the molds first may be coated with a release agent and prebaked.
  • the molded vulcanizate can be post cured in an oven at a temperature of about 140-240°C, preferably at a temperature of about 160-230°C, for a period of about 1-24 hours or more, depending on the cross-sectional thickness of the sample.
  • the temperature during the post cure is usually raised gradually from the lower limit of the range to the desired maximum temperature.
  • the maximum temperature used is preferably about 260°C and is held at this value for about 1 hour or more.
  • the cured fluoroelastomer is particularly useful as hoses, seals, gaskets, and molded parts in automotive, chemical processing, semiconductor, aerospace, and petroleum industry applications, among others.
  • O-rings (214, AMS AS568) were molded at 177 °C for 10 minutes at 400 kPa. The press cured O-rings were post cured at 250 °C for 16 hours. The post cured O-rings were tested for compression set for 70 hours at 200 °C in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with a 25% deflection. Results are reported as percentages.
  • the brown-colored slurry was washed with 250 grams deionized water and the top brown-colored organic phase was distilled to recover solvent with unreacted MA3.
  • the product contained CF 3 CF 2 CONH 2 amide by-product and no amidine product was identified by FTIR and NMR.
  • Example 1 Preparation of (HOCH 2 (CF 2 ) 5 OCFH) 3 -C 3 N 3 , (1H-MV5CH2OH)3 -Triazine
  • Example 3 Example 3 (Ex. 3) were 200 gram polymer batches that were compounded on a two-roll mill using the amounts listed in Table 2. These curable fluoropolymer compositions were then tested for their cure rheology and physical properties after press cure, physical properties after press cure and post cure, and their compression set. The results are shown in Table 3 below.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Described herein are compounds according to Formula (I) wherein each Rf is independently selected from a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1 to 3. A method of making the compound from a hydroxy-containing vinyl ether and excess ammonia is disclosed. In one embodiment, the hydroxy-ftmctionalized triazine compound is used in a curable fluoropolymer composition and cured to form articles.

Description

HYDROXY-FUNCTIONALIZED TRIAZINE COMPOUNDS. CURABLE
FLUOROPOLYMER COMPOSITIONS COMPRISING SUCH COMPOUNDS AND
CURED ARTICLES THEREFROM
TECHNICAL FIELD
[0001] A hydroxy-functionalized triazine compound is described along with a method of making such a compound. Also described are curable fluoropolymer compositions comprising such compounds and cured articles therefrom.
SUMMARY
[0002] There is a continuing desire to develop novel curing systems for fluoropolymers, which are more cost effective, have a higher efficiency of cure, and/or have improved
properties/performance.
[0003] In one aspect, a novel compound is described as shown in Formula (I)
wherein each Rf is independently selected from a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1 to 3.
[0004] In another aspect, a method of making the compound according to Formula (I) is described, the method comprising:
reacting a vinyl ether monomer according to Formula (II), with ammonia to form an amidine molecule; and heating the amidine molecule to form the compound according to Formula (I), where Formula (II) is
wherein Rf is a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1 to 3. [0005] In yet another aspect, a curable composition is described comprising (a) an amorphous fluorinated polymer capable of being dehydrofluorinated, and (b) the compound according to Formula I.
[0006] In one aspect, the curable composition from above is cured to form an article such as an o- ring, a seal, a gasket, a hose, or a sheet.
[0007] The above summary is not intended to describe each embodiment. The details of one or more embodiments of the invention are also set forth in the description below. Other features, objects, and advantages will be apparent from the description and from the claims.
DETAILED DESCRIPTION
[0008] As used herein, the term
“a”,“an”, and“the” are used interchangeably and mean one or more; and
“and/or” is used to indicate one or both stated cases may occur, for example A and/or B includes, (A and B) and (A or B);
“backbone” refers to the main continuous chain of the polymer;
“crosslinking” refers to connecting two pre-formed polymer chains using chemical bonds or chemical groups;
“cure site” refers to functional groups, which may participate in crosslinking;
“interpolymerized” refers to monomers that are polymerized together to form a polymer backbone;
“monomer” is a molecule which can undergo polymerization which then form part of the essential structure of a polymer;
“perfluorinated” means a group or a compound derived from a hydrocarbon wherein all hydrogen atoms have been replaced by fluorine atoms. A perfluorinated compound may however still contain other atoms than fluorine and carbon atoms, like oxygen atoms, chlorine atoms, bromine atoms and iodine atoms; and
“polymer” refers to a macrostructure having a number average molecular weight (Mn) of at least 30,000 dalton, at least 50,000 dalton, at least 100,000 dalton, at least 300,000 dalton, at least 500,000 dalton, at least, 750,000 dalton, at least 1,000,000 dalton, or even at least 1,500,000 dalton and not such a high molecular weight as to cause premature gelling of the polymer.
[0009] Also herein, recitation of ranges by endpoints includes all numbers subsumed within that range (e.g., 1 to 10 includes 1.4, 1.9, 2.33, 5.75, 9.98, etc.).
[0010] Also herein, recitation of“at least one” includes all numbers of one and greater (e.g., at least 2, at least 4, at least 6, at least 8, at least 10, at least 25, at least 50, at least 100, etc.). [0011] As used herein,“comprises at least one of" A, B, and C refers to element A by itself, element B by itself, element C by itself, A and B, A and C, B and C, and a combination of all three.
[0012] The present disclosure is directed toward a compound according to formula I. Along with a method of making such compound as well as their use curable fluoropolymer compositions.
[0013] Hydroxy-functionalized triazine compound
[0014] The hydroxy-functionalized triazine compounds of the present disclosure are according to Formula (I):
wherein each Rf is independently selected from a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1, 2, or 3.
[0015] It is to be appreciated that in the present disclosure, irrespective of what is depicted in any of the chemical structures, no representations are made regarding the stereoisomerism of the compounds and their spatial arrangement of atoms.
[0016] Rf is a divalent perfluorinated group comprising 2 to 12 carbon atoms. In one embodiment Rf comprises at least 2, 3, 4, 5, 6, or even 8 carbon atoms. In one embodiment Rf comprises at most 6, 8, 10 or even 12 carbon atoms. Rf may be linear, branched, and/or cyclic in nature. In one embodiment, Rf is linear alkylene, such as
-(CF2)n-, where n is an integer of at least 2, 3, or even 4; and at most 5, 6, 7, or even 8. In one embodiment, Rf is a branched alkylene such as -[(CF2CF(CF3)]n-, where n is an integer of at least 2, 3, 4; and at most 5, 6, 7, or even 8.
[0017] Rf may optionally contain at least one catenated oxygen (i.e., ether) and/or nitrogen (i.e., amine) atom. For example, Rf may comprise -(CF2)p-O-(CF2)q- , -(OCF2CF2)q- , -(OCF2CF(CF3))p- and/or -(CF2CF(CF3))p -O-(CF2)q- wherein p is an integer of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 and q is an integer from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11, such that the sum of p+q is 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12.
[0018] The Rf groups may or may not be same, however, it is preferable that the three Rf groups in Formula (I) are identical. [0019] The compound according to Formula I are small molecules, having a molecular weight of at least 600 g/mole and less than 5000, 4000, 3000, 2500, 2200, 2000, 1800, 1500, 1200, or even 1000 grams/mole.
[0020] Exemplary compounds of Formula (I) include:
[HOCH2(CF2)2OCFH]3-C3N3, [HO(CH2)2(CF2)2OCFH]3-C3N3,
[HO(CH2)3(CF2)2OCFH]3-C3N3, [HO(CH2)(CF2)3OCFH]3-C3N3, [HO(CH2)(CF2)4OCFH]3-C3N3, [HO(CH2)(CF2)5OCFH]3-C3N3,
[HO(CH2)(CF2)6OCFH]3-C3N3, [HO(CH2)(CF2)6OCFH]2-C3N3-[CHFO(CF2)2(CH2)OH],
[HO(CH2)(CF (CF3)O(CF2)6OCFH]2-C3N3-[CHFO(CF2)2OCF(CF3)CH2OH],
[HOCH2CH2CF(CF3)O(CF2)2OCFH]3-C3N3, [HOCH2CF(CF3)O(CF2)2OCFH]3-C3N3,
[HOCH2(CF2)3OCF(CF3)CF2OCFH]3-C3N3, [HOCH2CH2(CF2)4OCFH]3- C3N3,
[HOCH2(CF2)2OCF(CF3)CF2OCFH]3- C3N3,
[HOCH2CH2(CF2)2OCF2CF(CF3)OCFH]3- C3N3, and [HOCH2(CF2)5OCF(CF3)CF2OCFH]3- C3N3, where C3N3 represents the triazine ring.
[0021] Method of Making
[0022] The compounds according to Formula (I) may be made by reacting a hydroxy alkylene perfluorovinyl ether with excess ammonia to produce a hydroxy alkylene hydrofluoroether amidine. This reaction may be done directly or can be done in multiple steps by first isolating the hydroxy alkylene hydrofluoroether nitrile intermediate and adding additional ammonia to make the corresponding hydroxy alkylene hydrofluoroether amidine. These hydroxy alkylene
hydrofluoroether amidines can then be heated to isolate the trifunctional hydrofluoroether triazines.
[0023] The multi-step reaction to make the compound according to Formula (I) are shown below: HO(CH2)m-Rf-O-CF=CF2 + 3NH3 HO(CH2)m -Rf-O-CHF-CºN + 2HF·NH3
HO(CH2)m -Rf-O-CHF-CN + NH3 HO(CH2)m -Rf-O-CHF-C(=NH)NH2
3[HO(CH2)m -Rf-O-CHF-C(=NH)NH2] + heat Formula (I) + 3NH3
where Rf and m are the same as defined above.
[0024] In the above proposed reaction scheme, 1 mole of vinyl ether monomer of Formula (II) is reacted with three equivalents of ammonia to form a nitrile molecule of Formula (III). The amidine molecule of Formula (IV) can be derived by adding another mole of ammonia to the nitrile molecule of Formula (III) or adding excess ammonia to Formula (II) to isolate the amidine molecule directly. The amidine molecule of Formula (IV) can then be heated to arrive at the compound according to Formula (I). The formed nitrile molecule of Formula (III) can also be directly cyclized to form the compound of Formula (I) under heat, which can be accelerated, for example, in the presence of a catalytic amount of ammonia. [0025] The vinyl ether monomer is of the structure according to Formula (II):
wherein Rf is a perfluorinated divalent group as described above; and m is 1, 2, or 3.
[0026] Exemplary vinyl ether monomers according to Formula (II) include:
HOCH2(CF2)3OCF=CF2, HOCH2(CF2)5O CF=CF2,
HOCH2(CF2)3OCF(CF3)CF2O CF=CF2, HOCH2CH2(CF2)4OCF=CF2,
HOCH2(CF2)2OCF(CF3)CF2O CF=CF2, HOCH2CH2(CF2)2OCF(CF3)CF2OCF=CF2, and
HOCH2(CF2)5OCF(CF3)CF2O CF=CF2.
[0027] In the first step of the reaction disclosed herein, the vinyl ether monomer according to Formula (II) is reacted with a controlled amount (for example 3 moles of ammonia per mole of vinyl ether monomer) of ammonia (NH3) to form the corresponding nitrile molecule, HO(CH2)m- Rf-O-CHF-CN (III), wherein Rf and m are described above.
[0028] Exemplary nitrile molecules according to Formula (III) include:
HOCH2(CF2)3OCFHCN, HOCH2(CF2)5OCFHCN, HOCH2(CF2)3OCF(CF3)CF2OCFHCN
HOCH2CH2(CF2)4OCFHCN, HOCH2(CF2)2OCF(CF3)CF2OCFHCN,
HOCH2CH2(CF2)2OCF(CF3)CF2OCFHCN, and HOCH2(CF2)5OCF(CF3)CF2OCFHCN.
[0029] In the second step of the reaction, the corresponding nitrile molecule is reacted with an additional mole of ammonia to form the amidine molecule,
HO(CH2)m-Rf-O-CFH-C(=NH)NH2 (IV), in the presence of an excess amount of ammonia, wherein Rf and m are described above.
[0030] Exemplary amidine molecules according to Formula (IV) include:
HOCH2(CF2)3OCFHC(=NH)NH2, HOCH2(CF2)5OCFHC(=NH)NH2,
HOCH2(CF2)3OCF(CF3)CF2OCFHC(=NH)NH2, HOCH2CH2(CF2)4OCFHC(=NH)NH2,
HO(CH2)3(CF2)4OCFHC(=NH)NH2 HOCH2(CF2)2OCF(CF3)CF2OCFHC(=NH)NH2.
HOCH2CH2(CF2)2OCF(CF3)CF2OCFHC(=NH)NH2, and
HOCH2(CF2)5OCF(CF3)CF2OCFHC(=NH)NH2.
[0031] The amidine molecule is then heated to temperature of at least 100°C, 120°C, or even 140°C and, in some embodiments, at most 200°C, for cyclization of the amidine molecules to form the compound according to Formula (I) along with ammonia.
[0032] In the above reaction schemes, typically, a solvent is used to aid the reaction even though the reactions may be done in the absence of a solvent. Preferably, the selected solvent is a polar aprotic solvent, which has some solubility to the reactants to enable a fast reaction. Preferably, the used solvent is anhydrous in order to eliminate the hydrolysis side reaction of nitrile. Solvents that can be used, but not limited to are 1,4-dioxane, methyl -t-butyl ether, monoglyme, diglyme, triglyme, tetrahydrofuran, N-methyl pyrrolidone, N,N-dimethyl formamide, sulfolane, and acetonitrile. Methyl -t-butyl ether is the preferred solvent.
[0033] Addition of ammonia to the vinyl ether monomer to form the nitrile and/or amidine molecules can be done from -35°C to 50°C. Preferably from -10°C to 25°C and more preferably from -5°C to 10°C. Pressure in the reaction can range from 0 psi (pounds per square inch) to 100 psi, preferably from 10 psi to 75 psi and more preferably form 15 psi to 50 psi. The ratio of ammonia to the vinyl ether monomer to form the amidine molecule according to Formula (IV) can be from at least 3, 4, 5, 6, or even 7 moles of ammonia to 1 mole vinyl ether monomer. In one embodiment, the ratio of ammonia to the vinyl ether monomer of Formula (II) to form the amidine molecule according to Formula (IV) is no more than 8, or even 10 moles of ammonia to 1 mole of the vinyl ether monomer.
[0034] Depending on the reaction product desired, the desired reaction product can be isolated using techniques known in the art. For example, isolation of the nitrile molecule can be done by first filtration of the ammonium fluoride salt, removing the solvent by distillation or rotary evaporation and final distillation to isolate the nitrile molecule. A similar procedure is followed when isolating the amidine molecule, except the amidine molecule is not distilled. In one embodiment, the resulting triazine-containing compound according to Formula (I) is in a purified form, which means the compound according to Formula (I) is at least 75, 80, 85, 90, 95, 98, or even 99 wt% pure.
[0035] The reaction described above, is a straightforward reaction to produce hydroxy functionalized hydrofluoroether triazines. For example, dihydroalcohol perfluoropentyl vinyl ether, HOCH2(CF2)5OCF=CF2, which can be reacted with excess ammonia in methyl t-butyl ether solvent in a Parr reactor to isolate HOCH2(CF2)5OCFHC(=NH)NH2 then heated to 140°C to make [HOCH2(CF2)5OCFH]3-C3N3, a trihydroxy functional hydrofluoroether triazine.
[0036] The compounds according to Formula (I) may be used as a crosslinking agent in the curing of amorphous fluorinated polymers.
[0037] Curable Composition:
[0038] In one embodiment of the present disclosure, the compound according to Formula (I) is combined with an amorphous partially fluorinated polymer capable of being dehydrofluorinated to form a fluoroelastomer.
[0039] The amorphous partially fluorinated polymer capable of being dehydrofluorinated is a polymer comprising carbon-carbon double bonds and/or is capable of forming carbon-carbon double bonds along the polymer chain under desired curing conditions. [0040] The amorphous partially fluorinated polymer is a polymer comprising at least one carbon- hydrogen bond adjacent to a carbon-fluorine bond on the backbone of the polymer. In one embodiment, the amorphous partially fluorinated polymer is highly fluorinated, wherein at least 60, 70, 80, or even 90% of the polymer backbone comprises C-F bonds.
[0041] The amorphous partially fluorinated polymer of the present disclosure comprises carbon- carbon double bonds and/or is capable of forming carbon-carbon double bonds along the polymer chain. In one embodiment, the amorphous partially fluorinated fluoropolymer comprises carbon- carbon double bonds along the backbone of the partially fluorinated amorphous fluoropolymer or is capable of forming carbon-carbon double bonds along the backbone of the partially fluorinated amorphous fluoropolymer. In another embodiment, the amorphous partially fluorinated fluoropolymer comprises carbon-carbon double bonds or is capable of forming carbon-carbon double bonds in a pendent group off of the backbone of the partially fluorinated amorphous fluoropolymer.
[0042] The fluoropolymer capable of forming carbon-carbon double bonds means that the fluoropolymer contains units capable of forming double bonds. Such units include, for example, two adjacent carbons along the polymer backbone or pendent side chain, wherein a hydrogen is attached to the first carbon and a leaving group is attached to the second carbon. During an elimination reaction (e.g., thermal reaction, and/or use of acids or bases), the leaving group and the hydrogen leave forming a double bond between the two carbon atoms. An exemplary leaving group includes: a halide, an alkoxide, a hydroxide, a tosylate, a mesylate, an amine, an ammonium, a sulfide, a sulfonium, a sulfoxide, a sulfone, and combinations thereof. Also contemplated would be a fluoropolymer comprising adjacent carbons either having both bromine or both iodine atoms attached resulting in the leaving of Br2 or I2.
[0043] The amorphous partially fluorinated polymer comprises a plurality of these groups (carbon-carbon double bonds or groups capable of forming double bonds) to result in a sufficient cure. Generally, this means at least 0.1, 0.5, 1, 2, or even 5 mol % at most 7, 10, 15, or even 20 mol % (i.e., moles of these carbon-carbon double bonds or precursors thereof per mole of polymer).
[0044] In one embodiment, the amorphous partially fluorinated polymer is derived from at least one hydrogen containing monomer such as vinylidene fluoride.
[0045] In one embodiment, the amorphous partially fluorinated polymer comprises adjacent copolymerized units of vinylidene fluoride (VDF) and hexafiuoropropylene (H FP ): copolymerized units of VDF (or tetrafluoroethylene) and a fluorinated comonomer capable of delivering an acidic hydrogen atom to the polymer backbone, such as trifluoroethylene; vinyl fluoride; 3,3,3- trifluoropropene-1; pentafluoropropene (e.g., 2-hydropentafluoropropyiene and 1 - hydropentafluoropropylene); 2,3,3,3-tetrafluoropropene; and combinations thereof.
[0046] In some embodiments, small amounts (e.g., less than 10, 5, 2, or even 1 wt%) of additional monomers may be used to derive the amorphous partially fluorinated polymer so long as the fluorinated polymer is able to be cured with the compound of Formula (I) as disclosed herein, and optionally with a polyhydroxy curative.
[0047] In one embodiment, the amorphous partially fluorinated polymer is additionally derived from a hydrogen containing monomer including: pentafluoropropylene (e.g., 2- hydropentafluropropylene), propylene, ethylene, isobutylene, and combinations thereof.
[0048] In one embodiment, the amorphous partially fluorinated polymer is additionally derived from a perfluorinated monomer. Exemplary perfluorinated monomers include: hexafluoropropene; tetrafluoroethylene; chlorotrifluoroethylene; perfluoro ether monomers, and combinations thereof.
[0049] Exemplary perfluoro ether monomers are of the Formula (III)
CF2=CF(CF2)bO(Rf" O)n(Rf'O)mRf (III) where Rf" and Rf' are independently linear or branched perfluoroalkylene radical groups comprising 2, 3, 4, 5, or 6 carbon atoms, m and n are independently an integer selected from 0, 1,
2, 3, 4, 5, 6, 7, 8, 9, and 10, and Rf is a perfluoroalkyl group comprising 1, 2, 3, 4, 5, or 6 carbon atoms. Exemplary perfluoroalkyl vinyl ether monomers include: perfluoro (methyl vinyl) ether (PMVE), perfluoro (ethyl vinyl) ether (PEVE), perfluoro (n-propyl vinyl) ether (PPVE-1), perfluoro-2-propoxypropylvinyl ether (PPVE-2), perfluoro-3-methoxy-n-propylvinyl ether, perfluoro-2-methoxy-ethylvinyl ether, perfluoro-methoxy-methylvinylether (CF3-O-CF2-O- CF=CF2), and CF3-(CF2)2-O-CF(CF3)-CF2-O-CF(CF3)-CF2-O-CF=CF2. Exemplary perfluoroalkyl allyl ether monomers include: perfluoro (methyl allyl) ether (CF2=CF-CF2-O-CF3), perfluoro (ethyl allyl) ether, perfluoro (n-propyl allyl) ether, perfluoro-2-propoxypropyl allyl ether, perfluoro-3-methoxy-n-propylallyl ether, perfluoro-2-methoxy-ethyl allyl ether, perfluoro- methoxy-methyl allyl ether, and CF3-(CF2)2-O-CF(CF3)-CF2-O-CF(CF3)-CF2-O-CF2CF=CF2.
[0050] Exemplary types of amorphous partially fluorinated polymers include those comprising interpolymerized units derived from (i) vinylidene fluoride, tetrafluoroethylene, and propylene; (ii) vinylidene fluoride with hexafluoropropylene; (iii) hexafluoropropylene, tetrafluoroethylene, and vinylidene fluoride; (iv) hexafluoropropylene and vinylidene fluoride, (v) tetrafluoroethylene, propylene, and 3,3,3-trifluoropropene; (vi) tetrafluoroethylene, and propylene; and (vii) blends thereof. [0051] In one embodiment of the present disclosure, the amorphous partially fluorinated polymer is cured with the compound according to Formula (I) and is substantially free (having less than 0.05, less than 0.01, less than 0.05 wt% or even none relative to the amorphous partially fluorinated polymer) of a traditional curative (such as peroxide, and/or polyhydroxy curing agent). Typically, at least 0.05, 0.1, 1, 2, 3, or even 4 parts; and at most 5, 10, 15, 20, or even 25 parts by weight of the compound according to Formula (I) is used per 100 parts by weight of amorphous partially fluorinated polymer. The extent of the cure and performance can be evaluated by cure rheology, hardness, tensile properties (such as tensile at break, elongation at break, tensile at 50% elongation, and/or tensile at 100% elongation), and/or compression set.
[0052] In another embodiment of the present disclosure, the composition comprises a
dehydrofluorinating agent. Exemplary dehydrofluorinating agents include organoonium compounds, such as quaternary ammonium hydroxides or salts, quaternary phosphonium hydroxides or salts, and ternary sulfonium hydroxides or salts.
[0053] Briefly, a phosphonium and ammonium salts or compounds comprise a central atom of phosphorous or nitrogen, respectively, covalently bonded to four organic moieties by means of a carbon-phosphorous (or carbon-nitrogen) covalent bonds and is ionieally associated with an anion. The organic moieties can be the same or different.
[0054] Briefly, a sulfonium compound is a sulfur-containing organic compound in which at least one sulfur atom is covalently bonded to three organic moieties having from 1 to 20 carbon atoms by means of carbon-sulfur covalent bonds and is ionieally associated with an anion The organic moieties can be the same or different. The sulfonium compounds may have more than one relatively positive sulfur atom, e.g. [(C6H5)2 S+ (CH2)4S+(C6H5 ]2Cl-, and two of the carbon-sulfur covalent bonds may be between the carbon atoms of a divalent organic moiety , i.e., the sulfur atom may be a heteroatom in a cyclic structure.
[0055] Organo-onium compounds are known in the art, such as in U.S. Pat. No. 4,233,421 (Worm), U.S. Pat. No. 4,912,171 (Grootaert et al.), U.S. Pat. No. 5,086,123 (Guenthner et al.), and U.S. Pat. No. 5,262,490 (Kolb et al.), and U.S. Pat. No. 5,929,169, all of whose descriptions are herein incorporated by reference. Another class of useful organo-onium compounds include those having one or more pendent fluorinated alkyl groups. Generally, the most useful fluorinated onium compounds are disclosed in U.S. Pat. No. 5,591,804 (Coggio, et al.).
[0056] Exemplary organoonium compounds include: C3-C6 symmetrical tetraalkylammomum salts, unsymmetrical tetraalkylammonium salts wherein the sum of alkyl carbons is between 8 and 24 and benzyltrialkylammonium salts wherein the sum of alkyl carbons is between 7 and 19 (for example tetrabutylammonium bromide, tetrabutylammonium chloride, benzyltributylammonium chloride, benzyltriethylammomum chloride, tetrabutylammonium hydrogen sulfate and tetrabutylammonium hydroxide, phenyltrimethylammonium chloride, tetrapentylammonium chloride, tetrapropylammonium bromide, tetrahexylammonim chloride, and tetraheptylammonium bromidetetramethylammonium chloride); quatemary phosphonium salts, such as
tetrabutylphosphoniuin salts, tetraphenylphosphonium chloride, benzyltriphenylphosphonium chloride, tributylallylphospbonium chloride, tributylbenzyl phosphonium chloride, tributyl-2- methoxypropylphosphonium chloride, benzyldiphenyl(dimethylamino)phosphonium chloride, 8- benzyl-1,8-diazobicyclo[5.4.0]7-undecenium chloride, benzyltris(dimethylamino)phosphonium chloride, and bis(benzyldiphenylphosphine)iminium chloride. Other suitable organoonium compounds include 1 ,8-diazabicyclo[5.4.0]undec-7-ene and 1,5-diazabicyclo[4.3.0]non-5-ene. Phenolate is a preferred anion for the quaternary ammonium and phosphonium salts.
[0057] In one embodiment, the organoonium compound is used from at least 1, 1.5, 2, or even 2.5 millimoles and at most 3.5, 4, 4.5 or even 5 millimoles per 100 parts (by weight in grams) of the amorphous partially fluorinated polymer.
[0058] In one embodiment, the curable composition comprises an organic or inorganic base. Exemplary bases include Ca(OH)2, 1,8-diazobicyclo[5,4,0]undec-7-ene (DBU), triethylamine, and tributyl amine. 1,8-diazabicyclo(5.4.0)undec-7-ene salt (DBU salt), a 1,5-diazabicyclo(4.3.0)-non- 5-ene salt (DBN salt), and 1,5-diazabicyclo(4.3.0)-non-5-ene (DBN).
[0059] In one embodiment, the amorphous partially fluorinated polymer in curable composition, should be substantially free of iodine, bromine, and/or nitrile cure sites, meaning that the fluorinated polymer comprises less than 0.1, 0.05, 0.01, or even 0.005 wt% or even no I, Br, and CºN versus the weight of the amorphous partially fluorinated polymer.
[0060] The curable compositions can also contain a wide variety of additives of the type normally used in the preparation of elastomeric compositions, such as acid acceptors, process aides, pigments, fillers, pore-forming agents, and those known in the art.
[0061] Such fillers include: an organic or inorganic filler such as clay, silica (SiO2), alumina, iron red, talc, diatomaceous earth, barium sulfate, wollastonite (CaSiO3). calcium carbonate (CaCO3), calcium fluoride, titanium oxide, iron oxide and carbon black fillers, a polytetrafluoroethylene powder, PFA (TFE/perfluorovinyl ether copolymer) powder, an electrically conductive filler, a heat-dissipating filler, and the like may be added as an optional component to the composition. Those skilled in the art are capable of selecting specific fillers at required amounts to achieve desired physical characteristics in the cured product. The filler components may result in a cured product that is capable of retaining a preferred elasticity and physical tensile, as indicated by an elongation and tensile strength value, while retaining desired properties such as retraction at lower temperature (TR-10). [0062] In one embodiment, the curable composition and/or cured product comprises less than 40, 30, 20, 15, or even 10% by weight of the filler.
[0063] Conventional adjuvants may also be incorporated into the curable composition of the present disclosure to enhance the properties in the resulting cured product. For example, acid acceptors may be employed to facilitate the cure and thermal stability of the compound. Suitable acid acceptors may include magnesium oxide, lead oxide, calcium oxide, calcium hydroxide, dibasic lead phosphite, zinc oxide, barium carbonate, strontium hydroxide, calcium carbonate, hydrotalcite, alkali stearates, magnesium oxalate, or combinations thereof. The acid acceptors are preferably used in amounts ranging from at least 1, 2, 4, or even 5%; and at most 10, 15, or even 20 % weight per weight of the fluorinated polymer.
[0064] In one embodiment, the curable compositions (and the resulting cured articles) are substantially free of inorganic acid acceptors, meaning that the curable composition (or resulting cured article) contains less than 0.5, 0.1, 0.05, 0.01 % be weight per weight of the fluorinated polymer, or even no inorganic acid acceptor.
[0065] In one embodiment, the curable composition comprises a fluoroaliphatic sulfonamide. Such compounds can be used to improve the cure. Exemplary a fluoroaliphatic sulfonamides include C4F4SO2NHCH3, and CF3-(arylC6F4)-CF2SO2NHC2H5 as disclosed in U.S. Pat. No.
5,500,042. Such fluoroaliphatic sulfonamides may be used in at least 0.25, 0.5, 1, 2, or even 4 % and no more than 5, 8, or even 10% by weight based on the weight of the fluorinated polymer.
[0066] The curable compositions may be prepared by mixing the compound of Formula (I), the amorphous fluorinated polymer, and any additional components in conventional rubber processing equipment to provide a solid mixture, i.e. a solid polymer containing the additional ingredients, also referred to in the art as a“compound”. This process of mixing the ingredients to produce such a solid polymer composition containing other ingredients is typically called“compounding”. Such equipment includes rubber mills, internal mixers, such as Banbury mixers, and mixing extruders. The temperature of the mixture during mixing typically will not rise above about 120°C. During mixing the components and additives are distributed uniformly throughout the resulting amorphous fluorinated polymer“compound” or polymer sheets. The“compound” can then be extruded or pressed in a mold, e.g., a cavity or a transfer mold and subsequently be oven-cured. In an alternative embodiment, curing can be done in an autoclave.
[0067] Pressing of the compounded mixture (i.e., press cure) is typically conducted at a temperature of about 120-220°C, preferably about 140-200°C, for a period of about 1 minute to about 15 hours, usually for about 1-15 minutes. A pressure of about 700-20,000 kPa, preferably about 3400- 6800 kPa, is typically used in molding the composition. The molds first may be coated with a release agent and prebaked. [0068] The molded vulcanizate can be post cured in an oven at a temperature of about 140-240°C, preferably at a temperature of about 160-230°C, for a period of about 1-24 hours or more, depending on the cross-sectional thickness of the sample. For thick sections, the temperature during the post cure is usually raised gradually from the lower limit of the range to the desired maximum temperature. The maximum temperature used is preferably about 260°C and is held at this value for about 1 hour or more.
[0069] The cured fluoroelastomer is particularly useful as hoses, seals, gaskets, and molded parts in automotive, chemical processing, semiconductor, aerospace, and petroleum industry applications, among others.
EXAMPLES
[0070] Unless otherwise noted, all parts, percentages, ratios, etc. in the examples and the rest of the specification are by weight, and all reagents used in the examples were obtained, or are available, from general chemical suppliers such as, for example, Sigma-Millipore, Saint Louis, Missouri, or may be synthesized by conventional methods.
[0071] The following abbreviations are used in this section: g=grams, cm=centimeters, min=minutes, h=hours, °C=degrees Celsius, °F=degrees Fahrenheit, MPa=megapascals, mol=moles, wt%=weight percent, L=liters, mL=milliLiters, NMR=nuclear magnetic resonance, FTIR= Fourier transform infrared spectrophotometry, DSC=diffemtial scanning calorimetry, J=Joules. Abbreviations for materials used in this section, as well as descriptions of the materials, are provided in Table 1.
Table 1
[0072] Test Methods
[0073] Cure rheology
[0074] Cure rheology tests were carried out using uncured, compounded samples using a rheometer (PPA 2000 by Alpha technologies, Akron, OH), in accordance with ASTM D 5289-93A at 177 °C, no pre-heat, 12 minute elapsed time, and a 0.5 degree arc. Both the minimum torque (ML) and highest torque attained during a specified period of time when no plateau or maximum torque (MH) was obtained were measured. Also reported were the time for the torque to reach a value equal to ML + 0.5(MH - ML), (t' 50), and the time for the torque to reach ML + 0.9(MH - ML), (t'90). Results are reported in Table 3.
[0075] Physical Properties
[0076] Tensile, elongation, and modulus data were gathered from both press and post cured samples cut at room temperature to Die D specifications in accordance with ASTM 412-06A.
[0077] Molded O-rings and Compression Set
[0078] O-rings (214, AMS AS568) were molded at 177 °C for 10 minutes at 400 kPa. The press cured O-rings were post cured at 250 °C for 16 hours. The post cured O-rings were tested for compression set for 70 hours at 200 °C in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with a 25% deflection. Results are reported as percentages.
[0079] Comparative Example A (Comp. Ex. A): Reaction of perfluoropropyl ally ether, CF3CF2CF2OCF2CF=CF2 with ammonia
[0080] A 600 milliliter (mF) Parr reactor (Parr Instrument Company, Moline, IF, USA) was evacuated to 25 millimeter (mm) vacuum. The vacuum evacuated reactor was then charged with 50 grams (0.16 mol) C3F7OCF2CF=CF2 (MA3, made as described in U.S. Pat. No. 5891965 as PPAE-2) along with 150 grams of methyl tert-butyl ether. The reactor was stirred and cooled to -2 °C. The addition of 13 grams (0.77 mol) ammonia was then metered into the reactor over thirty minutes. No temperature increase was noted during the ammonia addition. The reactor was then warmed to 25 °C and the mixture was drained. The brown-colored slurry was washed with 250 grams deionized water and the top brown-colored organic phase was distilled to recover solvent with unreacted MA3. The product remaining after distillation of MA3, was analyzed. The product contained CF3CF2CONH2 amide by-product and no amidine product was identified by FTIR and NMR.
[0081] Example 1: Preparation of (HOCH2(CF2)5OCFH)3-C3N3, (1H-MV5CH2OH)3 -Triazine [0082] HOCH2C5F10OCF=CF2 was prepared as follows, perfluoroadipoyl fluoride was coupled with hexafluoropropylene oxide as described in U.S. Pat. Publication 2004/0116742 found in Example 3 to isolate FCO(CF2)5OCF(CF3)COF (boiling point of 135 °C). To a 2 Liter (L) 3-neck round bottom flask equipped with a mechanical stirrer, thermocouple, and condenser, 143 grams (1.35 mol) of sodium carbonate and 400 grams diglyme was added and stirred while heating to 82 °C. A charge of 250 grams (0.54 mol) FCO(CF2)5OCF(CF3)COF was added over one hour and stirred for an hour. The temperature was increased to 145 °C and held for two hours. The reaction mixture was the cooled to 38 °C and 365 grams of 60% sulfuric acid was added at a rate to keep the temperature below 60 °C. After acid addition, the mixture phase split to give the product in the top phase. The top phase was washed twice with 264 grams of 24% sulfuric acid to give the CF2=CFO(CF2)5CO2H product in the lower phase. Esterification to the methyl ester was done by adding 116 grams methanol followed by 64 grams of concentrated sulfuric acid to
CF2=CFO(CF2)5CO2H and heating to 82 °C for 20 hours. The solution was then cooled to 25 °C and 200 grams of distilled water was added to give the fluorochemical product in the lower phase. Vacuum distillation gave 110 grams (0.27 mol) CF2=CFO(CF2)5CO2CH3 boiling at 108 °C at 25 mm for a 50% yield. To a 1 L 3 -neck round bottom flask equipped with a mechanical stirrer, thermocouple, and condenser, 7.3 grams (0.19 mol) of NaBH4 and 165 g isopropanol was added and stirred while cooling to 5 °C. A charge of 110 grams (0.27 mol) CF2=CFO(CF2)5CO2CH3 was added over one hour and stirred for an hour at 5 °C. Dropwise, 205 grams of 14% sulfuric acid was then added over one hour at 5 °C. The solution was then stirred at 25 °C for 20 hours and subsequently charged with a mixture of 33 grams sodium chloride in 110 grams distilled water to get the product in the top phase with isopropanol. Atmospheric distillation of isopropanol followed by vacuum fraction gave 96 grams (0.25 mol) CF2=CFO(CF2)5CH2OH (MV5CH2OH with a boiling point of 68 °C at 13 mm vacuum for a 94% yield and 97.5% purity based on GC).
[0083] A 600 mL Parr reactor was evacuated to 25 mm vacuum. The vacuum evacuated reactor was then charged with 62 grams (0.16 mol) HOCH2(CF2)5OCF=CF2 along with 150 grams of methyl tert-butyl ether. The reactor was then stirred and cooled to -1 °C. The addition of 11 grams (0.65 mol) ammonia was metered into the reactor over thirty minutes which caused the temperature to rise to 4 °C. The reactor was then warmed to 25 °C and excess ammonia was vented. The mixture was then stirred at 25 °C for 20 hours. The resulting slurry was filtered through a glass-fritted funnel and the solvent was removed by atmospheric distillation. After the solvent was removed, the oil bath was set to 150 °C and held at that temperature for thirty minutes. Off-gassing was monitored through a bubbler. Heating was then stopped and the flask was cooled to 25 °C. FTIR analysis showed a strong peak at 1564 cm-1 for the triazine formation. Vacuum distillation yielded 27 grams (0.03 mol) of (HOCH2(CF2)5OCFH)3-C3N3, (1H-MV5CH2OH)3 - Triazine with boiling point of 260 °C at 11 mm for a 46% yield. 1H- and 19F-NMR confirmed the desired compound. GC/MS gave 87% purity. [0084] Example 2 (Ex. 2) and Example 3 (Ex. 3) were 200 gram polymer batches that were compounded on a two-roll mill using the amounts listed in Table 2. These curable fluoropolymer compositions were then tested for their cure rheology and physical properties after press cure, physical properties after press cure and post cure, and their compression set. The results are shown in Table 3 below.
Table 2.
Table 3. Physical Properties
[0085] Foreseeable modifications and alterations of this invention will be apparent to those skilled in the art without departing from the scope and spirit of this invention. This invention should not be restricted to the embodiments that are set forth in this application for illustrative purposes. To the extent that there is any conflict or discrepancy between this specification as written and the disclosure in any document mentioned or incorporated by reference herein, this specification as written will prevail.

Claims

What is claimed is:
1. A curable composition comprising (a) an amorphous fluorinated polymer capable of being dehydrofluorinated, and (b) a compound of Formula (I)
wherein each Rf is independently selected from a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1 to 3.
2. The curable composition of claim 1, wherein the molecular weight of compound of Formula (I) is less than 1500 grams/mole.
3. The curable composition of any one of the previous claims, wherein Rf is -(CF2)n-, where n is an integer from 2-8.
4. The curable composition of any one of claims 1-2, wherein Rf comprises
-(CF2)p-O-(CF2)q-, -(OCF2CF2)q-, -(OCF2CF(CF3))p- and/or -(CF2CF(CF3))p-O-(CF2)q-, wherein p is an integer of 1-1 1 and q is an integer from 1-1 1 , such that the sum of p+q is 2-12.
5. The curable composition of any one of the previous claims, wherein m is 1.
6. The curable composition of any one of the previous claims, wherein the compound according to Formula I is at least one of the following: [HOCH2(CF2)2OCFH]3-C3N3,
[HO(CH2)2(CF2)2OCFH]3-C3N3, [HO(CH2)3(CF2)2OCFH]3-C3N3, [HO(CH2)(CF2)3OCFH]3- C3N3, [HO(CH2)(CF2)4OCFH]3-C3N3, [HO(CH2)(CF2)5OCFH]3-C3N3,
[HO(CH2)(CF2)6OCFH]3-C3N3, [HO(CH2)(CF2)6OCFH]2-C3N3-[CHFO(CF2)2(CH2)OH], [HO(CH2)(CF (CF3)O(CF2)6OCFH]2-C3N3-[CHFO(CF2)2OCF(CF3)CH2OH],
[HOCH2CH2CF(CF3)O(CF2)2OCFH]3-C3N3, [HOCH2CF(CF3)O(CF2)2OCFH]3-C3N3, [HOCH2(CF2)3OCF(CF3)CF2OCFH]3-C3N3, [HOCH2CH2(CF2)4OCFH]3- C3N3,
[HOCH2(CF2)2OCF(CF3)CF2OCFH]3- C3N3, [HOCH2CH2(CF2)2OCF2CF(CF3)OCFH]3- C3N3, and [HOCH2(CF2)5OCF(CF3)CF2OCFH]3- C3N3, where C3N3 represents the triazine ring.
7. The curable composition of any one of the previous claims, comprising at least 0.1 part by weight of the compound of Formula (I) to 100 parts by weight of the amorphous fluorinated polymer capable of being dehydrofluorinated.
8. The curable composition of any one of the previous claims, wherein the amorphous fluorinated polymer capable of being dehydrofluorinated comprises at least one of (i) vinylidene fluoride, tetrafluoroethylene, and propylene copolymer; (ii) vinylidene fluoride and
hexafluoropropylene copolymer; (iii) hexafluoropropylene, tetrafluoroethylene, and vinylidene fluoride copolymer; (iv) hexafluoropropylene and vinylidene fluoride copolymer; (v) tetrafluoroethylene, propylene, and 3,3,3-trifluoropropene copolymer; (vi) tetrafluoroethylene, and propylene copolymer; and (vii) blends thereof.
9. The curable composition of any one of the previous claims, wherein the amorphous fluorinated polymer capable of being dehydrofluorinated comprises (i) at least one of vinylidene fluoride and tetrafluoroethylene, or (ii) a fluorinated comonomer having an acidic hydrogen atom.
10. The curable composition of claim 9, wherein the fluorinated comonomer having an acidic hydrogen atom comprises at least one oftrifluoroethylene; vinyl fluoride; 3,3,3- trifluoropropene-1; pentafluoropropene; and 2,3,3, 3-tetrafluoropropene.
11. The curable composition of any one of the previous claims, wherein the dehydrofluorinating agent is selected from an organo onium compound.
12. The curable composition of claim 11, wherein the organo onium compound is selected from at least one of quaternary ammonium hydroxides or salts, quaternary phosphonium hydroxides or salts, and ternary sulfonium hydroxides or salts.
13. The curable composition of any one of the previous claims, further comprising an organic or inorganic base.
14. The curable composition of any one of the previous claims, further comprising a sulfonamide.
15. A cured article derived from the curable composition of any one of the previous claims, optionally, wherein the cured article is an o-ring, a seal, a gasket, a hose or a sheet.
16. A molded article comprising the cured compositions of claim 15.
17. A method of making the compound according to Formula (I), the method comprising:
reacting a vinyl ether monomer according to Formula (II), with ammonia to form an amidine molecule; and heating the amidine molecule to form the compound according to Formula (I), where Formula (II) is
wherein Rf is a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1 to 3.
18. A method of preparing a shaped article comprising the steps of:
providing the curable composition of any of claims 1-14,
heating said composition to a temperature sufficient to cure the curable composition; and recovering the shaped article.
19. A compound according to Formula (I)
wherein each Rf is independently selected from a perfluorinated divalent group comprising 2 to 12 carbon atoms; and m is an integer independently selected from 1 to 3.
EP20737553.6A 2019-06-28 2020-06-22 Hydroxy-functionalized triazine compounds. curable fluoropolymer compositions comprising such compounds and cured articles therefrom Active EP3990438B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962868032P 2019-06-28 2019-06-28
PCT/IB2020/055859 WO2020261088A1 (en) 2019-06-28 2020-06-22 Hydroxy-functionalized triazine compounds. curable fluoropolymer compositions comprising such compounds and cured articles therefrom

Publications (2)

Publication Number Publication Date
EP3990438A1 true EP3990438A1 (en) 2022-05-04
EP3990438B1 EP3990438B1 (en) 2023-11-15

Family

ID=71527832

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20737553.6A Active EP3990438B1 (en) 2019-06-28 2020-06-22 Hydroxy-functionalized triazine compounds. curable fluoropolymer compositions comprising such compounds and cured articles therefrom

Country Status (4)

Country Link
US (1) US12428384B2 (en)
EP (1) EP3990438B1 (en)
CN (1) CN113950505B (en)
WO (1) WO2020261088A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024013242A (en) * 2022-07-20 2024-02-01 ユニマテック株式会社 Method for producing fluorine-containing alcohol having fluorovinyl group
CN116162016B (en) * 2023-01-09 2024-07-09 山东重山光电材料股份有限公司 Preparation method of pentafluoropentanol

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350806A (en) * 1971-12-03 1974-04-24 Pcr Trisubstituted triazines
US4233421A (en) 1979-02-26 1980-11-11 Minnesota Mining And Manufacturing Company Fluoroelastomer composition containing sulfonium curing agents
US5086123A (en) 1984-02-27 1992-02-04 Minnesota Mining And Manufacturing Company Fluoroelastomer compositions containing fluoroaliphatic sulfonamides as curing agents
US4912171A (en) 1988-04-01 1990-03-27 Minnesota Mining And Manufacturing Company Fluoroelastomer curing process with phosphonium compound
US5284611A (en) 1989-06-22 1994-02-08 Minnesota Mining And Manufacturing Company Fluoroelastomer composition with improved bonding properties
US5262490A (en) 1992-08-24 1993-11-16 Minnesota Mining And Manufacturing Company Fluoroelastomer composition with organo-onium compounds
JP3463318B2 (en) 1993-05-28 2003-11-05 旭硝子株式会社 Novel crosslinked perfluoropolymer and method for producing the same
JP4036474B2 (en) 1995-07-26 2008-01-23 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー Fluorinated alkenyltriazines and their use as crosslinking agents
ES2235195T3 (en) 1995-08-30 2005-07-01 Cytec Technology Corp. COMPOSITIONS CONTAINING 1,3,5-TRIAZINE CARBAMATES AND EPOXIDE COMPOUNDS.
US5591804A (en) 1995-12-21 1997-01-07 Minnesota Mining And Manufacturing Company Fluorinated onium salts, curable compositions containing same, and method of curing using same
US5891965A (en) 1997-01-06 1999-04-06 Dyneon Llc Low temperature perfluoroether-containing fluoroelastomers
JP3713870B2 (en) 1997-02-21 2005-11-09 ダイキン工業株式会社 Fluorine-containing nitrile and its polymer
US5728773A (en) 1997-02-21 1998-03-17 Minnesota Mining And Manufacturing Company Fluoroelastomer composition with organo-onium and blocked-carbonate compounds
US6794457B2 (en) 2001-04-30 2004-09-21 3M Innovative Properties Company Fluoropolymer curing system containing a nitrogen cure site monomer
US20040116742A1 (en) 2002-12-17 2004-06-17 3M Innovative Properties Company Selective reaction of hexafluoropropylene oxide with perfluoroacyl fluorides
US20050143529A1 (en) * 2003-12-30 2005-06-30 3M Innovative Properties Company Fluoropolymer compositions with nitrogen curing
US7402630B2 (en) 2004-12-16 2008-07-22 3M Innovative Properties Company Curing compositions for fluoropolymers
RU2319717C1 (en) * 2006-07-10 2008-03-20 Федеральное государственное унитарное предприятие "Научно-исследовательский институт синтетического каучука имени академика С.В. Лебедева" Composition based on copolymer of terafluoroethylene and perfluoroalkyl vinyl ethers
EP2646491B1 (en) 2010-12-03 2016-01-27 Solvay Specialty Polymers Italy S.p.A. Triazine derivative
WO2014206955A1 (en) 2013-06-28 2014-12-31 Solvay Specialty Polymers Italy S.P.A. Fluoroelastomers
WO2016123458A1 (en) * 2015-01-29 2016-08-04 Drexel University Thermoset polymers having a triazine network obtained by reaction of cyanate esters with dicyanamide room temperature ionic liquids

Also Published As

Publication number Publication date
US12428384B2 (en) 2025-09-30
CN113950505A (en) 2022-01-18
US20220227718A1 (en) 2022-07-21
CN113950505B (en) 2023-05-30
EP3990438B1 (en) 2023-11-15
WO2020261088A1 (en) 2020-12-30

Similar Documents

Publication Publication Date Title
JP6802164B2 (en) Curable partially fluorinated polymer composition
CN107318265A (en) Curable partially fluorinated polymer composition
EP3990438B1 (en) Hydroxy-functionalized triazine compounds. curable fluoropolymer compositions comprising such compounds and cured articles therefrom
US12084561B2 (en) Curable fluoropolymer compositions comprising bis phthalonitrile-containing compound and cured articles therefrom
WO2019159070A1 (en) Curable fluoroelastomer composition
KR102669338B1 (en) Curable Fluorinated Polymer Composition
US11919984B2 (en) Blends of crosslinking agents for fluoroelastomers
EP3775019A1 (en) Blends of crosslinking agents for fluoroelastomers
EP3990439B1 (en) Functionalized triazine compounds, compositions comprising such compounds and cured fluoropolymer articles
US20210324137A1 (en) Peroxide curable highly fluorinated polymers comprising an internal fluorinated plasticizer and articles therefrom
EP3807355B1 (en) Curable fluoroelastomer composition
EP3837309A1 (en) Curable fluoroelastomer composition

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211202

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20221124

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230609

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230818

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602020021122

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240216

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240315

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1631681

Country of ref document: AT

Kind code of ref document: T

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240315

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240216

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240215

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240315

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240215

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602020021122

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20240819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240622

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20240622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240630

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240622

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20240630

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250520

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231115

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20200622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20200622